The Porcine Epidemic Diarrhea Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for porcine epidemic diarrhea vaccines has seen robust growth in recent years. The market size is projected to increase from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The historical growth trend of the Porcine Epidemic Diarrhea Vaccines market has been strong.
The Porcine Epidemic Diarrhea Vaccines market is forecasted to grow to $2.42 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Porcine Epidemic Diarrhea Vaccines Market Report and Uncover Key Trends Now!The drivers in the porcine epidemic diarrhea vaccines market are:
• Large-scale vaccination campaigns
• Expanded programs on immunization (EPI)
• Adoption of disposable syringes
• Diarrhea eradication efforts
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
The trends in the porcine epidemic diarrhea vaccines market are:
• The future of the Porcine Epidemic Diarrhea Vaccines market is being shaped by continued innovations in vaccine delivery device technology.
• There is an increasing emphasis on needle-free solutions for vaccine administration.
• Advances in personalized medicine appear to be affecting the trajectory of this market.
• A growing preference for self-administered vaccines is also a notable trend.
The major players in the porcine epidemic diarrhea vaccines market are:
• Zoetis Inc.
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024